Categories: AnalystsSoftware

Global Maxfin analyst Garcea raises target on OpenText to $100

OpenText CEO Mark Barrenechea. OpenText (TSX:OTC) has a history of expertly integrating acquisitions, and the pickup of GXS Group is a huge positive, says Global Maxfin Capital analyst Ralph Garcea.

This morning, OpenText announced it plans to acquire Maryland-based based business-to-business cloud integrator GXS Group for (U.S.) $1.16-billion. CEO Mark Barrenechea explained the move.

“The next generation of enterprise software is enterprise information management,” he said. “Today’s GXS announcement strengthens the information exchange pillar with the addition of market-leading cloud-based B2B integration services, it expands the EIM buying centres and it strengthens EIM with the addition of cloud-based managed services. I look forward to welcoming GXS employees, customers and partners to Open Text in the near future.”

Garcea says that with the addition of GXS, OpenText could see fiscal 2015 revenue of $2.15-billion, adjusted EBITDA of $601-million, and adjusted earnings of $6.91.

The Global Maxfin analyst says the pickup of GXS will allow Open Text to combine its Information Exchange portfolio of products that includes Managed File Transfer, Capture and Secure email with GXS’s integration and managed services. He says that the growth of unstructured data in organizations means there is an increasing needs to manage content across multiple platforms. OpenText, he notes, has become a leader because its industry specific solutions are now critical for its Fortune 1000 clients.

In a research update to clients this morning Garcea maintained his BUY rating on OpenText, but increased his one-year price target to $100, up from his previous target of $87.

At press time, share of Open Text on the Nasdaq were up 9.3% to $81.30.

___________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: OTC
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

4 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

5 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

5 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

19 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago